Fundraising FoxRegenacy Pharmaceuticals
Waltham, US · Founded 2016 · Delaware corporation · 4 known investors
Find your way into Regenacy Pharmaceuticals
Sign up to see every warm intro you have to Regenacy Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Regenacy Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 4
3E Bioventures CapitalreportedPalo Alto
How we know: a partner's Signal profile · markets.financialcontent.com · Not right? Tell us
Cobro VenturesreportedMclean
How we know: funding news · markets.financialcontent.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28.7M disclosed across 2 rounds · 2020–2022
▶$7.8MraisedFeb 2022 · 9 investors · PharmaceuticalsRule 506(b)
▶$7.8MraisedFeb 2022 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daguang WangDirector
- William ChinDirector
- Simon JonesExecutive Officer, Director
- Shixiang YanDirector
- Michael L. HuangDirector
- Marc CohenExecutive Officer, Director
- John RochaExecutive Officer
- Offering amount
- $10M
- Amount sold
- $7.8M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.9MraisedApr 2020 · 19 investors · PharmaceuticalsRule 506(b)
▶$20.9MraisedApr 2020 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael L. HuangDirector
- Simon JonesExecutive Officer, Director
- William ChinDirector
- Shixiang YanDirector
- Daguang WangDirector
- Marc CohenExecutive Officer, Director
- John RochaExecutive Officer
- Offering amount
- $40.7M
- Amount sold
- $20.9M
- Sales commissions
- $757.5K
- Placement agents
- Locust Walk Partners, LLC
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Regenacy Pharmaceuticals's investors?
- Regenacy Pharmaceuticals's investors include 3E Bioventures Capital, Cobro Ventures, Taiwania Capital, Yonjin Venture LLC.
- How much funding has Regenacy Pharmaceuticals raised?
- Regenacy Pharmaceuticals has disclosed $28.7M raised across 2 rounds.
- Where is Regenacy Pharmaceuticals headquartered?
- Regenacy Pharmaceuticals is headquartered in Waltham, US.